{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+once+daily&page=50", "query": { "intervention": "Placebo once daily", "page": 50 }, "page_size": 10 }, "pagination": { "page": 50, "page_size": 10, "total_count": 5502, "total_pages": 551, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+once+daily&page=51&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+once+daily&page=49&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T12:51:48.213Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01834274", "title": "Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Fasiglifam (TAK-875)", "type": "DRUG" }, { "name": "Fasiglifam (TAK-875) Placebo", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Sitagliptin Placebo", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2013-06", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2015-09-28", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 44, "location_summary": "Huntsville, Alabama • Chandler, Arizona • Glendale, Arizona + 41 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01834274" }, { "nct_id": "NCT04655118", "title": "Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myelofibrosis", "Indolent Systemic Mastocytosis" ], "interventions": [ { "name": "TL-895", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Telios Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 121, "start_date": "2020-10-22", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2024-05-10", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 6, "location_summary": "Aurora, Colorado • Rochester, Minnesota • Canton, Ohio + 3 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Canton", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04655118" }, { "nct_id": "NCT06419608", "title": "Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "BHV-7000", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biohaven Therapeutics Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 336, "start_date": "2024-05-28", "completion_date": "2025-11-07", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 62, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Rogers, Arkansas + 54 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06419608" }, { "nct_id": "NCT01263808", "title": "Cardiac Safety of Indacaterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Indacaterol 150 µg", "type": "DRUG" }, { "name": "Indacaterol 300 µg", "type": "DRUG" }, { "name": "Indacaterol 600 µg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Placebo/moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 404, "start_date": "2008-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-12-21", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01263808" }, { "nct_id": "NCT04286789", "title": "Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Low dose ORTD-1", "type": "DRUG" }, { "name": "Low dose vehicle control", "type": "DRUG" }, { "name": "High dose ORTD-1", "type": "DRUG" }, { "name": "High dose vehicle control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oryn Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2021-03-22", "completion_date": "2021-10-12", "has_results": false, "last_update_posted_date": "2021-10-19", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 3, "location_summary": "Los Angeles, California • Tustin, California • Miami, Florida", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04286789" }, { "nct_id": "NCT00296491", "title": "Study Of Allergic Rhinitis In Patients Who Also Have Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol (FSC)", "type": "DRUG" }, { "name": "montelukast (MON)", "type": "DRUG" }, { "name": "fluticasone propionate (FP)", "type": "DRUG" }, { "name": "placebo nasal", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" }, { "name": "placebo capsule", "type": "DRUG" }, { "name": "placebo DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 725, "start_date": "2005-09", "completion_date": "2007-10", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 104, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Scottsdale, Arizona + 88 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00296491" }, { "nct_id": "NCT02911818", "title": "Lifestyle Modification and Liraglutide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "CMS-recommended lifestyle counseling", "type": "BEHAVIORAL" }, { "name": "Liraglutide 3.0mg", "type": "DRUG" }, { "name": "Portion-Controlled Diet", "type": "OTHER" }, { "name": "Placebo Oral Tablet", "type": "DRUG" }, { "name": "Phentermine 15 MG", "type": "DRUG" }, { "name": "Extension Study CMS-recommended lifestyle counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "DRUG", "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 150, "start_date": "2016-09", "completion_date": "2018-12", "has_results": true, "last_update_posted_date": "2019-05-07", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02911818" }, { "nct_id": "NCT01387230", "title": "Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "GSK573719", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 206, "start_date": "2011-07-01", "completion_date": "2012-02-13", "has_results": true, "last_update_posted_date": "2017-11-09", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 4, "location_summary": "Sunset, Louisiana • Easley, South Carolina • Spartanburg, South Carolina + 1 more", "locations": [ { "city": "Sunset", "state": "Louisiana" }, { "city": "Easley", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" }, { "city": "Union", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01387230" }, { "nct_id": "NCT00424528", "title": "Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Bronchitis", "Emphysema" ], "interventions": [ { "name": "Arformoterol Tartrate Inhalation Solution", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Arformoterol and Tiotropium", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 235, "start_date": "2006-12", "completion_date": "2007-10", "has_results": true, "last_update_posted_date": "2012-06-04", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 28, "location_summary": "Jasper, Alabama • Tucson, Arizona • San Diego, California + 25 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "DeFuniak Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00424528" }, { "nct_id": "NCT00505765", "title": "A Multicenter Study of NAP (AL-108) in Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "AL-108", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 63, "start_date": "2007-07", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2017-03-10", "last_synced_at": "2026-10-25T12:51:48.213Z", "location_count": 8, "location_summary": "Los Angeles, California • Catonsville, Maryland • Boston, Massachusetts + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Catonsville", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00505765" } ] }